The SLC33A1 gene helps move acetyl-CoA, a small energy-carrying molecule, into a part of the cell called the endoplasmic reticulum, where proteins are processed and cells stay balanced. If this transport does not work properly, nerve cells can be affected most. Pathogenic variants in the SLC33A1 gene are linked to inherited conditions that may cause leg stiffness and weakness, developmental delay, or eye problems. This gene is mainly known in genetics and neurology rather than in popular culture.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or guiding processes in the body. Some genes carry the information needed to produce proteins, which do much of the work inside cells. Other genes mainly regulate when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, and medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
SLC33A1Gene function
What if the gene works
The SLC33A1 gene helps move acetyl CoA, a small molecule cells use for energy and building, into the cell's protein processing area. This supports normal protein handling and fat production.
Risk
What if the gene does not work
Variants in the SLC33A1 gene can range from milder to more severe. Milder changes are linked to inherited leg stiffness and weakness, while more disruptive variants can cause an early-onset developmental condition with cataracts, hearing loss, and delayed development.
Treatment
What does that mean for your treatment
No SLC33A1-specific treatment or drug selection approach is currently established, so care is guided by your symptoms and overall clinical needs rather than by a pathogenic variant in the SLC33A1 gene itself.
Conditions associated with SLC33A1
Gene function
What if the gene works
In your cells, the SLC33A1 gene helps manage a small but important fuel called acetyl-CoA. Its protein sits in the membrane of the endoplasmic reticulum, a cell compartment that folds and prepares many proteins. This helps explain what the SLC33A1 gene does in your cells each day as proteins are processed and moved to where they are needed.
The SLC33A1 gene makes a transporter that moves acetyl-CoA, a small energy-rich building block, into the endoplasmic reticulum (the cell's protein processing area). This transfer gives that compartment the material it needs for routine protein handling.
Inside the endoplasmic reticulum, this gene supports acetylation (adding a small chemical tag) to certain proteins. That step can help proteins fold, mature, and move through the cell's shipping pathway in a controlled way.
Many proteins are prepared in the endoplasmic reticulum before they are sent to the cell surface or released outside the cell. By supplying acetyl-CoA in that compartment, the SLC33A1 gene supports this everyday protein traffic.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not produce any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change a gene’s function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many carrying SLC33A1 gene variants have changes that reduce how well this cell membrane transporter moves acetyl-CoA into the cell’s protein-processing area, which helps alter and stabilize newly made proteins. Some variants make the protein less stable or keep it from reaching the right membrane, while more disruptive variants can leave little or no transport activity. This range helps explain how SLC33A1 gene variants affect cell function, from partial loss to near-complete loss of activity.
How variants are linked to conditions
Pathogenic variants in the SLC33A1 gene are best known for causing hereditary spastic paraplegia type 42. In this SLC33A1 gene variant linked to hereditary spastic paraplegia, people often develop gradually increasing leg stiffness, weakness, and walking difficulty. Reports of other SLC33A1-related conditions exist, but hereditary spastic paraplegia type 42 is the most established and widely accepted association.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely found in the general population. Most do not directly affect health and simply represent natural variation among people. For many genes, carrying a variant associated with a condition indicates a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC33A1 gene. Risk usually depends most on the exact gene change and family history, and anyone worried about personal risk can talk with a doctor or genetic counselor.
Inheritance of SLC33A1 variants
How SLC33A1 variants are inherited depends on the specific SLC33A1-related condition. Some SLC33A1 gene variants are passed down in an autosomal dominant pattern, which means one altered copy from either parent can be enough, and each child of an affected parent has a 50% chance of inheriting it. Other SLC33A1 gene variants follow an autosomal recessive pattern, which means a child inherits one altered copy from each parent; when both parents are carriers, each pregnancy has a 25% chance that the child will inherit both altered copies. Because of this, inheritance can look different from one family to another.
What does my SLC33A1 result mean for my family?
SLC33A1 has been linked to more than one inherited condition, so what it means for relatives depends on the exact genetic change and diagnosis. In families with the dominant form, close relatives such as parents, siblings, and children may also carry the variant. In the recessive form, parents are often healthy carriers, and brothers or sisters may also be carriers or, less often, have the condition.
Genetic information
Genetic testing
How you find out about variants
Variants in the SLC33A1 gene are usually found through SLC33A1 genetic testing, using a blood sample or cheek swab. A lab reads the DNA code of the gene and checks for variants. Results can show whether a known disease causing variant is present and may help clarify a diagnosis or a family finding.
When should I consider getting a genetic test?
Genetic testing may be worth considering if there is a family history of inherited leg stiffness and weakness, or if a child has unexplained developmental delay with hearing, vision, or nerve problems that fit rare conditions linked to the SLC33A1 gene. A genetics specialist can help decide whether this gene should be included in a broader test panel.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal depends on the condition and on the kind of variant involved. Over time, the way the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most helpful when considered together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, or moves a drug, so the same treatment may work better for one person than for another. These differences are common and can influence how much benefit someone gets from a medication or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect their response to medications. It studies connections between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the SLC33A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices. Questions about side effects, how well a treatment is working, or any medication changes are best discussed with your doctor.